Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
As of: Oct 23, 2026 · 9:30 AM EDT

Mosaic ImmunoEngineering (CPMV) Gross Profit (2010 - 2011)

Updated

Mosaic ImmunoEngineering (CPMV) recorded Gross Profit of $35,274 in Q2 2012, compared with -$1,114 a year earlier and down 65.2% from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) Gross Profit (2010 - 2011) Analysis & Trends

On a TTM basis, Mosaic ImmunoEngineering's Gross Profit came in at $137,390 as of Nov 30, 2011.

  • Quarterly Gross Profit has ranged from -$1,114 in Q2 2011 to $101,479 in Q1 2012 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.49 Bn 1,099.07 Bn 19.71 Bn
2 Johnson & Johnson 635.65 Bn 555.51 Bn 17.30 Bn
3 AbbVie 505.44 Bn 478.55 Bn 12.70 Bn
4 Merck 358.27 Bn 312.65 Bn 12.21 Bn
5 Novartis Ag 291.57 Bn 255.56 Bn 11.24 Bn
6 Astrazeneca 265.15 Bn 238.84 Bn 12.86 Bn
7 Amgen 237.41 Bn 192.81 Bn 7.24 Bn
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn
9 Pfizer 171.23 Bn 117.87 Bn 10.94 Bn
10 Mosaic ImmunoEngineering 434,186.81 345,148.81 -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2011 35,274.00
Aug 31, 2011 101,479.00
Nov 30, 2010 -1,114.00
Aug 31, 2010 1,751.00
API Access

Mosaic ImmunoEngineering Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CPMV&period=max&api_key=YOUR_API_KEY